CYCLE Pilot Randomized Trial (CYCLE Pilot)

November 30, 2022 updated by: McMaster University

CYCLE Pilot: A Pilot Randomized Study of Early Cycle Ergometry Versus Routine Physiotherapy in Mechanically Ventilated Patients

Background: Patients in the intensive care unit (ICU) are the sickest in hospital, and need advanced life-support. Survivors of critical illness are very weak and disabled. Up to 1 in 4 have severe leg weakness impairing their quality of life for as long as 5 years after ICU discharge. In-bed cycling involves use of special equipment that attaches to a patient's hospital bed, allowing them gentle exercise while in the ICU.

Methods: Adult patients admitted to the ICU who need a breathing machine and are expected to survive their ICU stay are eligible. Patients will randomly receive 30 minutes of in-bed cycling each day they are in the ICU or routine physiotherapy, both delivered by specially trained physiotherapists.

Outcomes: Feasibility: The investigators will study whether patients can cycle on most days of their ICU stay, whether patients and their families agree to be a part of the study, and whether investigators can systematically assess patients' strength.

Relevance: Effective methods of physiotherapy are needed for critically ill patients to minimize muscle weakness, speed recovery, and improve quality of life. This pilot randomized study is the second of several future larger studies about in-bed cycling in the ICU.

Our pilot work includes CYCLE Pilot and CYCLE Vanguard. CYCLE Pilot is an external pilot and enrolled 66 patients from 3/2015 to 6/2016. CYCLE Vanguard is an internal pilot and enrolled 47 patients from 11/2016 to 3/2018. CYCLE Vanguard patients will be analyzed in the main CYCLE RCT (NCT03471247).

Study Overview

Study Type

Interventional

Enrollment (Actual)

113

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Victoria
      • Melbourne, Victoria, Australia, 3084
        • Austin Health
    • Ontario
      • Hamilton, Ontario, Canada, L8N 4A6
        • St. Joseph's Healthcare Intensive Care Unit
      • Hamilton, Ontario, Canada
        • Hamilton Health Sciences General ICU
      • Hamilton, Ontario, Canada
        • Hamilton Health Sciences Juravinski ICU
      • London, Ontario, Canada
        • London Health Sciences
      • Ottawa, Ontario, Canada
        • Ottawa General Hospital
      • Toronto, Ontario, Canada
        • St. Michael's Hospital
      • Toronto, Ontario, Canada
        • Toronto General Hospital
    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults admitted to a medical-surgical ICU within the 1st 4 days of mechanical ventilation (MV) and 1st 7 days of ICU, and
  • could ambulate independently before hospital admission.

Exclusion Criteria:

  • Acute condition impairing patients' ability to cycle (e.g., leg fracture),
  • proven or suspected neuromuscular weakness affecting the legs (e.g., stroke or Guillain-Barré syndrome),
  • unable to follow commands in English pre-ICU,
  • temporary pacemaker,
  • expected hospital mortality >90%,
  • unable to fit the bike, palliative goals of care, or persistent therapy exemptions in the 1st 4 days of MV (e.g., cardiorespiratory instability, active major bleeding)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early Cycling and routine physiotherapy
Patients will receive 30 minutes of in-bed cycling in addition to routine physiotherapy, 5 days per week, for the duration of their ICU stay
Other Names:
  • Restorative Therapies RT300 Supine
Active Comparator: Routine physiotherapy
Patients will receive routine physiotherapy per current institutional practice
activities to assist with optimizing airway clearance and respiratory function, and, based on the patient's alertness and medical stability, activities to maintain or increase limb range of motion and strength, in- and out of bed mobility, and ambulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Patient accrual
Time Frame: 2 years
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cycling protocol violations (% cycling protocol violations)
Time Frame: 2 years
% cycling protocol violations
2 years
Outcome measure ascertainment (% outcomes measured in hospital)
Time Frame: 2 years
% outcomes measured in hospital
2 years
Blinded outcome measures at hospital discharge (% outcomes at hospital discharge measured by blinded outcome assessors)
Time Frame: 2 years
% outcomes at hospital discharge measured by blinded outcome assessors
2 years
Physical Function Test for ICU (PFIT) at ICU awakening, ICU discharge, 3-days post-ICU discharge (CYCLE Vanguard only) and hospital discharge
Time Frame: From study admission to approximately 5, 12, 15 and 30 days, on average, respectively
Patients complete 4 activities: arm and leg strength, ability to stand, and step cadence. Scores range from 0 to 10, with higher scores = better function
From study admission to approximately 5, 12, 15 and 30 days, on average, respectively
Muscle strength at ICU awakening, ICU discharge, 3-days post-ICU discharge (CYCLE Vanguard only), and hospital discharge
Time Frame: From study admission to approximately 5, 12, 15 and 30 days, on average, respectively
Manual muscle testing using the Medical Research Council (MRC) Scale. The patient exerts a force against the examiner's resistance. Each muscle is assessed on a 6-point MRC scale (0=no contraction; 5=contraction sustained against maximal resistance).
From study admission to approximately 5, 12, 15 and 30 days, on average, respectively
Quadriceps strength at ICU and hospital discharge (Force measured in Kg and in Newtons on a continuous scale)
Time Frame: From study admission to approximately 12 and 30 days, on average, respectively
The patient exerts a force against a small strain gauge that fits in the examiner's hand. .
From study admission to approximately 12 and 30 days, on average, respectively
2 minute walk test at ICU discharge, 3-days post-ICU (CYCLE Vanguard only), and hospital discharge
Time Frame: From study admission to approximately 12 and 30 days, on average, respectively
Maximum distance walked in 2 minutes measured in metres on a continuous scale
From study admission to approximately 12 and 30 days, on average, respectively

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Katz Activities of Daily Living Scale at ICU and hospital discharge
Time Frame: From study admission to approximately 12 and 30 days, on average, respectively
The patient's ability to complete 6 tasks: bathing, dressing, toileting, feeding, continence, and bed mobility. A rater assesses whether the patient is dependent or independent according to pre-specified criteria.
From study admission to approximately 12 and 30 days, on average, respectively
Euro-QOL 5DL
Time Frame: From study admission to approximately 12 and 30 days, on average, respectively
5 question self-administered, preference-based instrument to measure mobility, self-care, usual activities, pain, and anxiety/ depression, as well as a global assessment of health
From study admission to approximately 12 and 30 days, on average, respectively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2015

Primary Completion (Actual)

March 1, 2018

Study Completion (Actual)

December 1, 2018

Study Registration Dates

First Submitted

February 26, 2015

First Submitted That Met QC Criteria

March 3, 2015

First Posted (Estimate)

March 4, 2015

Study Record Updates

Last Update Posted (Actual)

December 5, 2022

Last Update Submitted That Met QC Criteria

November 30, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • HIREB 14-531

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure

Clinical Trials on In-bed cycle ergometer (Restorative Therapies RT300 Supine)

3
Subscribe